Q3 FY21 Financial Performance - Revenue reached $211 million[9] - Non-GAAP gross margin was 36%[10] - Non-GAAP EPS was $0.40[10] - Cash reserves totaled $128 million[10] Revenue Trends and Mix - Medical segment revenue was $167 million[20] - Industrial segment revenue was $44 million[20] - Revenue distribution by region: Americas $66 million, EMEA $76 million, and APAC $69 million[22] China Market - FY21 revenues from China are expected to exceed $100 million[15] - Over half of China revenues are from Medical Tubes[15] Q4 FY21 Outlook (Non-GAAP) - Revenue is projected to be between $205 million and $225 million[35] - EPS is expected to be between $0.25 and $0.40[35] - Gross margin is anticipated to be between 35% and 36%[37] - Operating expenses are estimated to be between $46 million and $47 million[37]

VAREX Solutions in Sight™ Q2 FY21 Earnings Presentation May 4, 2021 Proprietary and Confidential Information Forward Looking Statements / Non-GAAP Measures Forward Looking Statements Certain statements in this supplement contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward looking statements include statements concerning industry or market outlook; addressable market, market size; the potential be ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________ FORM 10-Q ____________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 2, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 ____________ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________ FORM 10-Q ____________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 1, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 __________ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________ FORM 10-K ____________________________________________________________ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended October 2, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 _________________________ ...

Varex Imaging Corporation (NASDAQ:VREX) Q4 2020 Results Conference Call November 17, 2020 5:00 PM ET Company Participants Howard Goldman - Director of Investor Relations Sunny Sanyal - President, Chief Executive Officer Sam Maheshwari - Chief Financial Officer Conference Call Participants Anthony Petrone - Jefferies Larry Solow - CJS Securities Suraj Kalia - Oppenheimer & Company Jim Sidoti - Sidoti & Company Operator Greetings! Welcome to Varex Imaging Corporation’s Fourth Quarter and Fiscal Year Full Year ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________ FORM 10-Q ____________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 3, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 _____________ ...

Varex Imaging Corporation (NASDAQ:VREX) Q3 2020 Earnings Conference Call August 12, 2020 5:00 PM ET Company Representatives Sunny Sanyal - President, Chief Executive Officer Sam Maheshwari - Chief Financial Officer Clarence Verhoef - Retiring Chief Financial Officer Howard Goldman - Director of Investor Relations Conference Call Participants Larry Solow - CJS Securities Anthony Petrone - Jefferies Suraj Kalia - Northland Security Jim Sidoti - Sidoti & Company Mark Strouse - JP Morgan Operator Greetings! And ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________ FORM 10-Q ____________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 3, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 ____________ ...

Varex Imaging Corporation (NASDAQ:VREX) Q2 2020 Earnings Conference Call May 12, 2020 5:00 PM ET Company Representatives Sunny Sanyal - President, Chief Executive Officer Clarence Verhoef - Chief Financial Officer Howard Goldman - Director of Investor Relations Conference Call Participants Anthony Petrone - Jefferies Larry Solow - CJS Securities Suraj Kalia - Oppenheimer Mark Strouse - JP Morgan Jim Sidoti - Sidoti & Company Operator Greetings! And welcome to Varex Imaging Corporation, Second Quarter Fiscal ...